Combining magnetic and direct current transcranial stimulations was more effective than either treatment alone for major ...
TUSCANY study is open to enroll patients to receive TUS+VEN+AZA triplet at select US sitesFavorable safety and broad clinical ...
During the Phase III BROOKLYN trial, patients were randomly assigned in a 2:1 ratio to receive either obicetrapib 10mg or a ...
Donald Trump’s return to the White House presents an opportunity to overhaul federal dietary guidelines, which lack ...
- VY1706 is the fifth neuro gene therapy development candidate nominated leveraging Voyager’s IV-delivered, CNS-penetrant TRACER capsids - ...
NIH-developed AI algorithm matches potential volunteers to clinical trials: Bethesda, Maryland Wednesday, November 20, 2024, 17:00 Hrs [IST] Researchers from the National Institut ...
Before long Covid there was post-viral fatigue – a mysterious set of illnesses caused by other infections. Now scientists are ...
Backed by a Strong Balance Sheet, MIRA Accelerates Toward Becoming a Clinical-Stage Company and Advancing Breakthroughs in Pain and Depression Treatment ...
A first-of-its-kind study in India has focussed on optimal drug combinations for managing hypertension in the country.
KarXT - Nicola Rizzo Pesci and Andrea Cipriani summarise findings from the EMERGENT-2 trial spotlighting a promising new ...
Cytokinetics, Bayer enter collaboration and licensing pact to develop & commercialize aficamten in Japan: South San Francisco, California Wednesday, November 20, 2024, 15:00 Hrs [ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback